ACCREDATION

Ananta Medicare demonstrates an unwavering commitment to excellence through its comprehensive suite of global accreditations and certifications across its manufacturing facilities. The flagship cephalosporin injectable plant in Sriganganagar, inaugurated in 2020, adheres to rigorous international Good Manufacturing Practice (GMP) standards. It holds coveted certifications — EU GMP (via Portugal audit), PIC/S GMP (Ukraine and Thailand), Philippines GMP, WHO GMP (India), and a UAE Manufacturing Site Registration Certificate.

Complementing this, the company’s second facility—launched in 2023—focuses on oral solid dosage forms and has achieved PIC/S GMP (Ukraine) and WHO GMP certification. Meanwhile, its dietary supplement and herbal product site, operational since 2015, is accredited with WHO GMP, ISO 9001, ISO 22000, HACCP, and HALAL standards, ensuring uncompromising product quality from raw materials to distribution

All three facilities also comply with Good Laboratory Practice (GLP) and Good Distribution Practice (GDP), enforcing strict quality control from sampling to shipping . This layered approach—co

vering vaccines, oral medications, and nutraceuticals—highlights Ananta’s dedication to international best practices and reassures stakeholders of its reliability, safety, and therapeutic integrity.

Scroll to Top